Karyopharm Therapeutics reported $-36279000 in Pre-Tax Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbott ABT:US USD 2.49B 486M
AstraZeneca AZN:LN USD 3.09B 52M
Enanta Pharmaceuticals ENTA:US USD -26334000 5.81M
GlaxoSmithKline GSK:LN GBP 2.43B 602M
Johnson & Johnson JNJ:US USD 8.07B 98M
Karyopharm Therapeutics KPTI:US USD -36279000 12.66M
Macrogenics MGNX:US USD -24813000 16.49M
Mirati Therapeutics MRTX:US USD -173307000 3.14M
Nektar Therapeutics NKTR:US USD -59204000 99.76M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 10.67B 3.11B
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Sangamo Biosciences SGMO:US USD -53125000 10.03M
Takeda 4502:JP JPY 64.55B 90.92B
Tg Therapeutics TGTX:US USD -35818000 4.69M
Ultragenyx Pharmaceutical RARE:US USD -238819000 80.96M
Xencor XNCR:US USD -31671000 2.3M
YTE INCY:US USD 178.22M 131.36M